Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 907, pseudogene (RNU6-907P) is a pseudogene located in the human genome, and is annotated as having homology to the U6 small nuclear RNA, a molecule essential for the splicing of precursor messenger RNA (pre-mRNA) in the spliceosome complex. Unlike functional U6 small nuclear RNA genes, RNU6-907P is a non-functional copy or remnant that does not code for a functional RNA product and is not known to participate in gene regulatory or protein-coding activities. Pseudogenes are typically classified as non-coding RNAs, and while some pseudogenes in other families may exert regulatory effects through RNA interactions, there is no evidence that RNU6-907P has biological roles, disease associations, or is considered a therapeutic target. Pseudogenes are widespread in the genome and may in some cases regulate parental gene expression or interact with cellular miRNA machinery, but such functions are described for other pseudogenes and not RNU6-907P specifically. It is assigned HGNC ID: 47870 and NCBI Gene ID: 106480620, confirming its annotation as a human pseudogene. The nomenclature is standardized in gene databases, and the name, abbreviation, and classification are widely accepted. If you require structured data for knowledge bases, RNU6-907P should be excluded from lists of therapeutic targets or druggable genes; it is a genomic feature of interest for genomics and bioinformatics, but not for pharmacology or clinical development.
None known; pseudogenes generally are not directly targeted by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 907, pseudogene (RNU6-907P).